- Disease: Acute COVID-19
- Study type: Observational Cohort Study, Treatment
- Study type descriptors: Retrospective, Single centre
- Objective: To evaluate the efficacy and safety of molnupiravir in treating COVID-19 in a real-life cohort
- Number of participants enrolled: 192
- Study enrolling from to
- Study includes follow-up for 1 month
Study Data
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Hospital
- Emergency department
- SARS-CoV-2
- Acute COVID-19
- Pharmacological intervention
- Antivirals
- Molnupiravir
External Links
Other information
Funders/Sponsors:
- Università degli Studi di Sassari, Italy
The information was provided with the aid of the study investigators
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to